Drawing for THE BINDING SITE

USPTO serial 77331874

THE BINDING SITE

Reviewed by CopyMark Law Group

Reg. 3479719Status 800Registered
Filing date
Status date
Registration date
Aug 5, 2008
Examiner
BAKER, JORDAN A
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with THE BINDING SITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kenya Williams

Kenya Williams Thermo Fisher Scientific5781 Van Allen WayCarlsbad, CA 92008United States

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic kits comprised of diagnostic reagents for laboratory use, calibrators, reagent plates, buffered solutions, diluent solutions, and serum; Reagents, diagnostic reagents, biological reagents, histology reagents, enzyme radioimmunoassay reagents, immunoassay reagents, antigen substrates, and antibodies for scientific research use; and test kits comprised of reagents, buffers, calibrators, diluents, antibodies, antigen substrates, conjugates, stopping solutions, antisera and/or dropper bottles for scientific and research use using blood, body fluids, body tissues or extracts thereof; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Chemicals, namely, buffer and standard solutions used in analytical chemistry; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific use; Diagnostic preparations used in science; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Reagents for chemical analyses; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; electrophoresis gels other than for medical or veterinary purposesACTIVE—
005Calibrating solutions, diluents, control samples, reagents, antibodies, antigen substrates, conjugates, stopping solutions, immunofluorescence reagents, histology reagents, enzyme immunoassay reagents and general purpose reagents for medical and veterinary diagnostic and clinical use; and diagnostic and immunological test kits consisting of reagents, controls, buffers, calibrators, diluents, antibodies, antigen substrates, conjugates, stopping solutions, antisera and/or dropper bottles, all for use in measuring the concentration of proteins, antibodies, antigens and other substances in blood, other body fluids and body tissues, or extracts thereof, for use in the diagnosis, treatment, cure, prevention or mitigation of diseases and other conditions in humans and animals; biological and chemical preparations and reagents for medical or veterinary use; Clinical medical reagents; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for medical and veterinary use; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; medical diagnostic kits for use in electrophoresis, immunology and serology, consisting primarily of extracts from blood or body fluids; control solutions indicative of a positive result for medical use; buffer solutions for diluting samples and/or reagents for medical use; reagents, blood reagents; electrophoretic gels for medical purposes; protein stain, for visualizing results, for medical purposes; antisera for precipitating specific proteins, for medical purposes; fixative for precipitating proteins, for medical purposes; templates for controlling the application of samples and/or antisera, for medical purposes; blotting paper and blotting tissues for removing excess liquid for gels, for medical purposesACTIVE—
009Apparatus for testing gas, liquids and solids; and electronic apparatus for electrophysiological measurement and testing of cells; blank magnetic data carriers; computer software for use in data manipulation and instrument control for use in measuring the concentration of proteins, antibodies, antigens and other substances in body fluids for use in the diagnosis, treatment, prevention, cure and mitigation of diseases and other conditions in humans; and nephelometers for use in measuring the concentration of proteins, antibodies, antigens and other substances in body fluids for use in the diagnosis, treatment, prevention, cure and mitigation of diseases and other conditions in humans; electronic and computerized radial immunodiffusion plate readers; electrophoresis tank and power supply, for laboratory use; gel presses for pressing and drying gels; laboratory equipment, namely, incubatorsACTIVE—
010Medical diagnostic apparatus and instruments for the diagnosis, treatment and cure of diseases in humans, namely, multiple myeloma, lymphocytic neoplasms, Waldenstrom's macroglobulinemia, amyloidosis, light chain deposition diseases and connective tissues diseases, namely, systemic lupus erythematosus; apparatus for blood, urine and serum analysis; apparatus for clinical diagnosis; apparatus used in implementing diagnostic tests designed to detect abnormalities in blood, serum and urine, namely, automated clinical analyzers based on colorimetric and turbidmetric measurements, diluents, reagents, calibrators, and control serum; and medical diagnostic apparatus and analytical apparatus for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 12, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 12, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 26, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 26, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 26, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 26, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 26, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 26, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 26, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 15, 2017NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Sep 15, 2017RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Sep 15, 201789AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Sep 15, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 7, 2017E89RTEAS SECTION 8 & 9 RECEIVED—
Aug 5, 2017REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Aug 22, 2013NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Aug 22, 2013C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Aug 22, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 5, 2013815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Aug 5, 2013E815TEAS SECTION 8 & 15 RECEIVED—
Aug 31, 2011ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Mar 15, 2011CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 15, 2011COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 8, 2009ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 5, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 20, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 30, 2008NPUBNOTICE OF PUBLICATION—
Apr 16, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 15, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 15, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Apr 15, 2008GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 15, 2008GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 15, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 15, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 15, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 15, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 15, 2008ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 4, 2008PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 27, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 27, 2008ALIEASSIGNED TO LIE—
Mar 12, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 4, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 4, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 4, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2008DOCKASSIGNED TO EXAMINER—
Nov 21, 2007MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Nov 20, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance